CLB vs LEN · P/E 21, rev $526.5M vs rev $34.19B
Core Laboratories NV (CLB) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Core Laboratories NV (CLB) is a oil & gas equipment & services company listed on US.
LEN (LEN) common stock.
Latest reported CLB revenue for 2025-12-31 was $526.5M. Net income was $29.7M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CLB currently screens at market cap $596.0M and trailing P/E 21.2.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CLB currently screens at market cap $596.0M and trailing P/E 21.2. LEN currently screens at market cap $0.
Not investment advice. Open the CLB and LEN stock pages for the full models.
Not investment advice.